News

Join us to discuss HEOR, market access and real-world evidence.

See how the impact of the pandemic has highlighted the use of digital therapeutics.

Talk with our team about how we can support you in the fight against rare diseases.

We are delighted to see that OPEN VIE is a Finalist, not once but twice, in this year's Communiqué Awards!

Today is Juneteenth and we celebrate it every year. But this year isn’t like most years. 

Jeff Anderson appointed as European Lead for OPEN VIE and Pharmerit Europe

We stand behind our diverse, inclusive, and equitable culture. We demand equality, opportunity, and justice for all.

Jordana brings expertise across a wide range of projects in Real-World Evidence

The need to demonstrate value to multiple stakeholders in a dynamic healthcare landscape has driven an increasing intersection between traditional Health Economics and Outcomes Research and Medical Affairs functions, globally. Digital technologies have emerged as tools over the past few years to strengthen collaborations and engagement, and their use is accelerating in the midst of the global COVID-19 pandemic.

At this most difficult time we wanted to reach out and first express our concern for your safety and health. This is an unprecedented situation in our lifetimes where we should work together and support each other to overcome this challenge.

Meet two of OPEN Health’s practices—Peloton Advantage and Pharmerit International—at booth #4 at MAPS Global 2020, the World's Largest Assembly of Medical Affairs Professionals, to be held in Miami, Florida from March 8 – 11, 2020.

Join Pharmerit and OPEN Health on our journey in 2020

Patients increasingly want to be more involved in their healthcare, decisions about it and research towards its improvement, and there are some shining examples of patients moving front and centre to lead discussions.

Dr. Patti Peeples, CEO of HealthEconomics.com, sat down with Walter Bouwmeester, Real-World Evidence and Data Analytics Lead in Europe, to discuss the use of data analytics to support multidimensional health economics and outcomes research (HEOR) in Europe.

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

Pharmerit International (Pharmerit), a leading provider of health economics and outcomes research (HEOR) and market access research services, has announced the opening of a new office in Oxford, UK.

Pharmerit International (Pharmerit), a leading health economics and outcomes research (HEOR) consultancy, is expanding its Asian presence. The expansion includes the growth of the Shanghai, China, office as well as establishment of an office in Mumbai, India.

This holiday season, we take a moment to thank our sponsors for the partnerships we have formed in demonstrating value together.